Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2022-11-09 00:00:00 ET · period of report 2022-11-07 · accession 0001415889-22-011244 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-09 | 2022-11-07 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $66.06 | +7,411 | 3,795 | New | +$489.5K |
| DM | 2022-11-09 | 2022-11-07 | UTHR | EDGEMOND JAMES | CFO AND Treas | D - Sale to Iss | $266.80 | -7,411 | 1,384 | -84% | -$1.98M |
| DM | 2022-11-09 | 2022-11-07 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $0.00 | -7,411 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-07 | M | A | 5,000 | $52.12 | 6,384 | D | — | — | (F1) Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. (F2) Includes 23 shares acquired on September 4, 2019, 297 shares acquired on March 4, 2020, 156 shares acquired on March 4, 2021, 58 shares acquired on September 3, 2021, 97 shares acquired on March 4, 2022 and 26 shares acquired on September 2, 2022, under the United Therapeutics Corporation Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2022-11-07 | D | D | 5,000 | $266.80 | 1,384 | D | — | — | (F1) Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. |
| 3 | Common | Common Stock | 2022-11-07 | M | A | 2,411 | $94.96 | 3,795 | D | — | — | (F1) Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. |
| 4 | Common | Common Stock | 2022-11-07 | D | D | 2,411 | $266.80 | 1,384 | D | — | — | (F1) Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. |
| 5 | Derivative | Share Tracking Award | 2022-11-07 | M | D | 5,000 | $0.00 | 0 | D | $52.12 · 2015-02-28 to 2023-01-14 | 5,000 Share Tracking Award | (F1) Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. |
| 6 | Derivative | Share Tracking Award | 2022-11-07 | M | D | 2,411 | $0.00 | 0 | D | $94.96 · 2015-03-14 to 2024-03-14 | 2,411 Share Tracking Award | (F1) Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. |